Friday, October 18, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Doctors Cash In: The Hidden Profits Behind Pediatric Vaccinations

Doctors Cash In: The Hidden Profits Behind Pediatric Vaccinations

Healthcare providers for years have been leading the charge in recommending—and often pressuring—parents to vaccinate their children. During the COVID-19 pandemic, strong endorsements from pediatricians played a significant role1 in the acceptance of experimental COVID-19 shots for kids, while parents expressed dismay at receiving dismissal letters for delaying or refusing a barrage of shots. What these […]

FDA Licenses First At-Home Administered Influenza Vaccine

FDA Licenses First At-Home Administered Influenza Vaccine

The U.S. Food and Drug Administration (FDA) has licensed  the first of its kind live attenuated nasal spray influenza vaccine that can be administered at home. Adults up to the age 49 will be eligible to self-administer the FluMist Home vaccine or give it to their children two to 17 years old as long as […]

CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns

CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns

The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]

WHO Declares Monkeypox a Global Health Emergency

WHO Declares Monkeypox a Global Health Emergency

On Aug. 14, 2024, the World Health Organization (WHO) declared monkeypox (mpox) a public health emergency of international concern (PHEIC). “Today, the Emergency Committee met and advised me that in its view, the situation constitutes a public health emergency of international concern. I have accepted that advice,” said WHO Director-General Tedros Adhanom Ghebreyesus,1 2 3 […]

FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine

FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine

On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.’s new pneumococcal conjugate vaccine Capvaxive (formerly V116) for adults 18 years of age and older. The vaccine is designed to protect against 21 types of the bacteria causing pneumococcal disease, which can lead to severe infection in the lungs […]

RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome

RSV Vaccines for Senior Adults Linked to Guillain-Barré Syndrome

On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).1 When a person develops GBS, including after an infection or […]

Search in Site

To search in site, type your keyword and hit enter

Search